Microproteinuria during Opisthorchis viverrini infection: A biomarker for advanced renal and hepatobiliary pathologies from chronic Opisthorchiasis by Saichua, Prasert et al.
Himmelfarb Health Sciences Library, The George Washington University
Health Sciences Research Commons
Microbiology, Immunology, and Tropical Medicine
Faculty Publications Microbiology, Immunology, and Tropical Medicine
5-23-2013
Microproteinuria during Opisthorchis viverrini
infection: A biomarker for advanced renal and
hepatobiliary pathologies from chronic
Opisthorchiasis
Prasert Saichua
Khon Kaen University School of Medicine, Khon Kaen, Thailand
Paiboon Sithithaworn






Khon Kaen University School of Medicine, Khon Kaen, Thailand
See next page for additional authorsFollow this and additional works at: https://hsrc.himmelfarb.gwu.edu/smhs_microbio_facpubs
Part of the Medical Immunology Commons, Medical Microbiology Commons, Parasitic
Diseases Commons, and the Parasitology Commons
This Journal Article is brought to you for free and open access by the Microbiology, Immunology, and Tropical Medicine at Health Sciences Research
Commons. It has been accepted for inclusion in Microbiology, Immunology, and Tropical Medicine Faculty Publications by an authorized
administrator of Health Sciences Research Commons. For more information, please contact hsrc@gwu.edu.
Recommended Citation
Saichua, P., Sithithaworn, P., Jariwala, A.R., Deimert, D.J., Sithithaworn, J., et al. (2013) Microproteinuria during Opisthorchis
viverrini Infection: A Biomarker for Advanced Renal and Hepatobiliary Pathologies from Chronic Opisthorchiasis. PLoS Neglected
Tropical Diseases 7(5): e2228.
Authors
Prasert Saichua, Paiboon Sithithaworn, Amar R. Jariwala, David J. Diemert, Jiraporn Sithithaworn, Banchob
Sripa, Thewarach Laha, Eimorn Mairiang, Chawalit Pairojkul, Maria V. Periago, Narong Khuntikeo, Jason
Mulvenna, and Jeffrey M. Bethony
This journal article is available at Health Sciences Research Commons: https://hsrc.himmelfarb.gwu.edu/smhs_microbio_facpubs/
64
Microproteinuria during Opisthorchis viverrini Infection:
A Biomarker for Advanced Renal and Hepatobiliary
Pathologies from Chronic Opisthorchiasis
Prasert Saichua1, Paiboon Sithithaworn2,3*, Amar R. Jariwala4, David J. Deimert4, Jiraporn Sithithaworn5,
Banchob Sripa6, Thewarach Laha2, Eimorn Mairiang7, Chawalit Pairojkul7, Maria Victoria Periago8,
Narong Khuntikeo9, Jason Mulvenna10, Jeffrey M. Bethony4*
1 Biomedical Sciences Program, Graduate School, Khon Kaen University, Khon Kaen, Thailand, 2 Department of Parasitology, Faculty of Medicine, Khon Kaen University,
Khon Kaen, Thailand, 3 Liver Fluke and Cholangiocarcinoma Research Center, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand, 4 Department of
Microbiology, Immunology and Tropical Medicine and Center for the Neglected Diseases of Poverty, George Washington University, Washington, D.C., United States of
America, 5 Department of Clinical Microscopy, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand, 6 Department of Pathology, Faculty of
Medicine, Khon Kaen University, Khon Kaen, Thailand, 7 Department of Radiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand, 8 Insituto René
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Abstract
Approximately 680 million people are at risk of infection with Opisthorchis viverrini (OV) and Clonorchis sinensis, with an
estimated 10 million infected with OV in Southeast Asia alone. While opisthorchiasis is associated with hepatobiliary
pathologies, such as advanced periductal fibrosis (APF) and cholangiocarcinoma (CCA), animal models of OV infection show
that immune-complex glomerulonephritis is an important renal pathology that develops simultaneously with hepatobiliary
pathologies. A cardinal sign of immune-complex glomerulonephritis is the urinary excretion of immunoglobulin G (IgG)
(microproteinuria). In community-based studies in OV endemic areas along the Chi River in northeastern Thailand, we
observed that over half of the participants had urine IgG against a crude OV antigen extract (OV antigen). We also observed
that elevated levels of urine IgG to OV antigen were not associated with the intensity of OV infection, but were likely the
result of immune-complex glomerulonephritis as seen in animal models of OV infection. Moreover, we observed that urine
IgG to OV antigen was excreted at concentrations 21 times higher in individuals with APF and 158 times higher in
individuals with CCA than controls. We also observed that elevated urine IgG to OV antigen could identify APF+ and CCA+
individuals from non-cases. Finally, individuals with urine IgG to OV antigen had a greater risk of APF as determined by Odds
Ratios (OR = 6.69; 95%CI: 2.87, 15.58) and a greater risk of CCA (OR = 71.13; 95%CI: 15.13, 334.0) than individuals with no
detectable level of urine IgG to OV antigen. Herein, we show for the first time the extensive burden of renal pathology in OV
endemic areas and that a urine biomarker could serve to estimate risk for both renal and hepatobiliary pathologies during
OV infection, i.e., serve as a ‘‘syndromic biomarker’’ of the advanced pathologies from opisthorchiasis.
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Introduction
Foodborne trematodiases represent an important group of
communicable diseases, and some of the most clinically significant
neglected tropical diseases (NTDs) affecting East Asia. Approxi-
mately 680 million people are at risk of infection with the human
liver flukes Opisthorchis viverrini and Clonorchis sinensis [1]. In
Southeast Asia alone, up to 67 million people are at risk of
infection with O. viverrini (OV), with 10 million people estimated to
be infected with this pathogen in the Mekong Basin Subregion of
Thailand and Lao PDR [2,3]. Humans become infected with OV
by consuming raw or undercooked fish that contain the infective
metacercarial stage (for review see [4]). Although the infection can
be eliminated by the anthelminthic praziquantel, environmental
and cultural factors of the Mekong Basin region strongly favor re-
infection [4]. Despite mass drug administration (MDA) efforts in
the northeast region of Thailand (Isaan), the prevalence of OV
remains intransigently high [5,6].
Our community-based ultrasound studies in O. viverrini endemic
areas along the Chi River Basin in Khon Kaen, Thailand have
revealed that significant morbidity occurs early during the course
of chronic OV infection, including advanced hepatobiliary
PLOS Neglected Tropical Diseases | www.plosntds.org 1 May 2013 | Volume 7 | Issue 5 | e2228
pathologies such as advanced bile duct (periductal) fibrosis (APF)
and bile duct cancer (cholangiocarcinoma or CCA) [7,8]. As
individuals do not become symptomatic until the late stages of
these diseases, early detection remains an important public health
objective [4,6]. Although renal disease is not usually considered
among the more critical pathologies of chronic opisthorchiasis, as
with many other parasitic infections (e.g. Plasmodium spp, Schistosoma
spp, Filarioidea) [9], glomerulopathy has been reported in laboratory
animal models of OV infection [10,11]. More specifically, early
during experimental OV infection (8 weeks), hamsters develop a
‘‘mesangioproliferative glomerulonephritis’’, characterized by the
deposition of immune complexes (ICs) consisting of immunoglob-
ulin (Ig) G, complement component 3 (C3), and OV tegumental
antigen [10]. After 12 weeks, the infected hamsters show a
complete obsolesce of the glomeruli characterized by deposition of
amyloid (AA protein), tubular atrophy, interstitial inflammation,
and tubular fibrosis, all of which are co-incident with APF and
CCA [10]. It is interesting to note that a deterioration in renal
function has been reported in humans with obstructive jaundice
due to OV-associated CCA in endemic areas of Thailand [12],
although this is likely a manifestation of ‘hepatorenal syndrome’
(HRS), a common end stage complication of chronic hepatic
diseases, such as liver cirrhosis and liver cancer [13].
Previous studies have attempted to show a correlation between
the intensity of OV infection and levels of urine IgG to various
crude OV antigen extracts [14–16]. Although urine can contain
small quantities of ‘intact’ immunoglobulin as well as light and
heavy chain fragments of immunoglobulin, the restrictive pore
radius of the renal glomerular filter in a healthy human kidney
would not filter macromolecules the size of intact IgG (for review
see [17]). As such, the frequent observation of elevated levels of
urine IgG to OV antigen in areas of high OV transmission [14–
16] most likely reflects structural damage from immune complex
deposition in the glomeruli as observed in the hamster model of
OV infection [10,11]. In the current manuscript, we investigated
the presence of urine IgG to a crude adult OV antigen extract
(OV antigen) in residents from OV endemic areas along the Chi
River Basin, in Khon Kaen Thailand. Our hypothesis is that if
levels of urine IgG to OV antigen are elevated in individuals with
renal and hepatobiliary pathologies, then this non-invasive and
easily assayed biomarker could serve as a single marker for both
pathologies, i.e., as a ‘‘syndromic biomarker’’ of advanced pathologies
from chronic opisthorchiasis.
Materials and Methods
Study sample and study design
This study uses baseline data from the Khon Kaen Cancer
Cohort (KKCC), which was conducted in seven (7) villages with
high OV transmission along the Chi River Basin in Khon Kaen
Thailand. A detailed description of the KKCC and the methods
used to assemble this cohort can be found in several manuscripts
[7,8,18]. The dataset from the KKCC included 296 individuals
divided into three clinical groups described below and shown in
Table 1. In brief, 148 males and 148 females were enrolled in the
KKCC. Of the males and females in this dataset, 256 (86.4%)
were infected with OV as determined by microscopic fecal
examination. Participants in the KKCC were classified into groups
based on abdominal ultrasound (US) examination and microscopic
fecal examination for OV infection. Group 1 consisted of 40
individuals considered ‘‘Endemic Normals’’ (EN), who were age,
sex and ‘nearest-eligible-neighbor’ matched with cases (Group 3)
and were OV negative (OV2) and APF negative (APF2) as
determined by abdominal US. Group 2 consisted of 139
individuals considered ‘‘controls’’, who were age, sex and
‘nearest-eligible-neighbor’ matched to cases (Group 3) and were
OV positive (OV+) and APF negative (APF2). Group 3 consisted
of 117 individuals considered ‘‘cases‘‘ who were APF positive
(APF+). Group 4 was not part of the KKCC and consisted of 98
individuals with histologically proven opisthorchiasis-associated
CCA whose serum and urine samples were obtained from the
biological specimen repository of the Liver Fluke and Cholangio-
carcinoma Research Center, Khon Kaen University, Thailand.
Individuals positive for infection with OV were referred to the
local public health outpost for treatment with praziquantel.
Ethics statement
All subjects in Groups 1–3 provided written informed consent
using forms approved by the Ethics Committee of Khon Kaen
University School of Medicine, Khon Kaen, Thailand (reference
number HE480528) and the Institutional Review Board of the
George Washington University School of Medicine, Washington,
D.C (GWUMC IRB# 020864). The serum and urine from Group
4 was obtained from the biological specimen repository of the
Liver Fluke and Cholangiocarcinoma Research Center, Khon
Kaen University, Thailand using a protocol approved by the
Ethical Committee on Human Research, Faculty of Medicine,
Khon Kaen University, Thailand (reference Nos. HE450525 and
HE531061).
Clinical assessment and specimen acquisition
Assessment of hepatobiliary status was done by abdominal US
with positive findings scored as APF+ or APF2 as previously
described [7,8]. Two fecal samples were collected on consecutive
days from each participant in Groups 1–3; fecal samples were not
available for Group 4 patients (CCA cases). OV infection was
determined and quantified (eggs per gram of feces or epg) by
microscopic fecal examination using the formalin-ethyl acetate
concentration technique (FECT) as described by Elkins et al [19]
on two consecutive days of fecal samples. In addition, the following
samples were also collected from Groups 1–3: thirty (30) milliliters
(ml) of venous blood collected into siliconized tubes after overnight
Author Summary
Approximately 680 million people risk infection with food-
borne trematodes, including Opisthorchis viverrini (OV).
Animal models show that significant kidney pathology
results from OV infection as detected by antibodies in
urine (microproteinuria). However, kidney pathology in
humans infected with OV is often overlooked because it
develops alongside more severe pathologies such as bile
duct fibrosis and bile duct cancer. In Northeastern Thai-
land, the researchers observed that OV infected individuals
had elevated levels of urine IgG against OV antigen that
was not associated with the level of OV infection. The
researchers observed that urine IgG to OV antigen was
associated with bile duct fibrosis and bile duct cancer.
Moreover, individuals with urine IgG to OV antigen also
had elevated risk of bile duct fibrosis and bile duct cancer
than individuals with no urine IgG to OV antigen. For the
first time, OV infection has been shown to result in
significant kidney disease in humans, which is also strongly
associated with bile duct pathology. A urine-based assay
that could indicate both renal and bile duct pathology
from OV infection would be of profound benefit in
Southeast Asia, especially in the resource-limited settings
of the Mekong Basin region countries of Thailand, Laos
and Cambodia.
Renal Biomarkers for Chronic Opisthorchiasis
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fasting and first morning mid-stream urine samples collected into
sterile containers. Venous blood samples were allowed to clot at
room temperature for 30 minutes after collection, centrifuged, and
the serum removed and aliquoted for storage stored at 220uC in a
temperature-monitored freezer. Urine samples were centrifuged
and the supernatant aliquoted and stored at 220uC in a
temperature-monitored freezer. In the case of CCA patients
(Group 4), serum or urine specimens were obtained by simple
random sampling from the collection of biological specimens in
the repository of the Liver fluke and Cholangiocarcinoma
Research Center, Khon Kaen University, Thailand.
Point of care testing for proteinuria
Individual subjects were asked to provide morning urine into
clean polypropylene containers that were kept on ice during
transportation to the laboratory. Unprocessed urine samples were
screened for protein by urine strip (ARKRAY’s AUTION Sticks,
Japan) and then analyzed using an Automated Urine Chemistry
Analyzer (AUTION MAX AX-4280, Arkray, USA).
Preparation of crude adult O. viverrini antigen extract
Adult O. viverrini worms from experimentally infected hamsters
were washed three times with sterile phosphate buffered saline (PBS
pH 7.2) containing 0.149 M sodium chloride (Fisher Scientific, NJ),
8.29 mM disodium hydrogen phosphate (Acros Organics, NJ) and
18 mM sodium dihydrogen phosphate monohydrate (Fisher
Scientific, NJ) in deionized (DI) water. A 1006Protease Inhibitor
Cocktail (Calbiochem, CA) was added to the worms in PBS, which
were then homogenized using a tissue grinder on ice. The worm
pellet was homogenized by ultrasonic disintegrator (MISONIC
sonicator 3000, US) and then centrifuged at 4uC, 14000 rpm for
30 min. The BCATM Protein Assay kit (PIERCE, IL) was used to
determine the protein yield of the crude somatic O. viverrini adult
antigen extract. The supernatant was collected and stored at 280uC
until used.
Development of a qualified indirect enzyme-linked
immunosorbent assay (ELISA) for quantification of
antibodies to a crude OV adult antigen extract
Flat-bottom 96-well microtiter plates (Maxisorb, NUNC, DN)
were coated with 1 mg/ml of crude somatic O. viverrini adult
antigen in PBS buffer (pH 7.2), which was then covered with
sealing film and incubated overnight at 4uC in the dark. On the
next day, the plates were washed 5 times with a buffer containing
0.05% Tween20 in PBS (pH 7.2) using an automated plate washer
(Thermoelectron, MA). After washing, 250 ml of a blocking buffer
containing 5% BSA (Fitzgerald, MA) in PBS and 0.5% Tween-20
(Fisher, NJ) was added to all wells, and the plates incubated at
room temperature (RT) for 1 hour. Serum samples were diluted in
a buffer which contained 5% BSA (Fitzgerald, MA) in PBS and
0.5% Tween-20 (Fisher, NJ), and added to wells (100 mL/well) in
duplicates and incubated overnight at 4uC. Undiluted urine
supernatants were added to wells (100 mL/well) in duplicate and
incubated overnight at 4uC. The plates were then washed 5 times
with a buffer of PBS and 0.5% Tween-20, and a horseradish
peroxidase (HRP)-conjugated secondary antibody was added to all
wells and incubated for 2 hours at RT. HRP-goat anti human IgG
(Zymed, CA) was used to detect IgG in serum and urine. HRP-
mouse anti-human IgG1 (Southern Biotech, AL), and an HRP-
mouse anti-human IgG4 (Zymed, CA) were used to detect IgG1
and IgG4 in serum, respectively. After incubation and washing, a
substrate solution, which consisted of Ortho phenylenediamine
Table 1. Characteristics of the study participants in the Khon Kaen Cancer Cohort (KKCC) and CCA cases.
Group 1 Group 2 Group 3 Group 4
Characteristic Endemic Normal* OV+ APF2{ APF+ CCA+` Total
N = 40 139 117 98 394
Sex
Male 13 (32%) 76 (54.7%) 59 (50.4%) 59 (60%) 207
Female 27 (68%) 63 (45.3%) 58 (49.6%) 39 (40%) 187
Age
Mean 6 SD 4967.55 4768.32 47610.17 5969.52
Intervals
#30 0 (0%) 2 (1%) 5 (4%) 0 (0.0%) 7
31–40 6 (15%) 30 (22%) 28 (24%) 4 (4%) 68
41–50 14 (35%) 63 (45%) 32 (27%) 13 (13%) 122
.50 20 (50%) 44 (32%) 52 (44%) 81 (83% 197
OV infection
Egg/gram feces
0 40 (100%) – – – 40
1–499 – 123 (88%) 97 (83.%) – 220
$500 – 16 (12%) 20 (17%) – 36
*Endemic Normal refers to individuals who are ‘‘negative’’ for OV infection and for APF;
{Advanced Periductal Fibrosis as determined by abdominal ultrasound.
`Cholangiocarcinoma.
Study participant recruited from O. viverrini endemic areas along the Chi River Basin in Khon Kaen, Thailand from 2010 to 2012, as part of the Khon Kaen Cancer Cohort
(KKCC). This includes individuals with confirmed OV-associated cholangiocarcinoma (CCA) from the biological specimen repository of the Liver fluke and
Cholangiocarcinoma Research Center, Khon Kaen University, Thailand.
doi:10.1371/journal.pntd.0002228.t001
Renal Biomarkers for Chronic Opisthorchiasis
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(Sigma, MO), 53 mM citric acid anhydrous (Fisher, NJ), 102 mM
dibasic sodium phosphate dodecahydrate (Acros Organics, NJ)
and 30% w/w hydrogen peroxide (Fisher, NJ) in DI water was
added to the wells and incubated at RT in the dark for 30 min.
The reaction was stopped by the addition of 2N sulfuric acid
(BDH, PA) and the plates were read using a plate reader
(SpectraMax 340PC384 system) at 492 nm.
Development of an indirect ELISA to measure IgG to OV-
antigen in urine and serum
Following the method of Quinn and colleagues [20–22], we
developed a diagnostic assay using an indirect ELISA that
incorporates ‘‘homologous interpolation’’ to determine the con-
centration of an analyte (e.g., anti-OV IgG) in either diluted serum
or undiluted urine supernatant samples by interpolation of test
serum or urine supernatant OD at 492 nm onto a Standard
Calibration Curve (SCC) run on each microtitre plate. Briefly, a
Standard Reference Sera (SRS) and urine Standard Reference
Solution (SRS) were made by pooling of sera or urine supernatants
with known high levels of IgG and its subclasses against Ov
antigen from individuals who were O. viverrini egg positive (see
references for details of this method [20–22]). Each serum SRS
and the urine SRS are serially diluted on each microtiter plate in
two-fold steps using a dilution buffer (5% Bovine Serum Albumin
in PBS and 0.5% Tween-20 at a pH of 7.2). The ODs of each
dilution point are then used to generate the SCC by 4-PL
regression modeling (SOFTmax PRO version 5.4 software)
[23,24]. To generate the SCC, Arbitrary Units (AU) of antibody
are assigned to the Standard Calibration Curves as shown in Table
S1. The 4-PL function is used to model the characteristic curve for
the SRS. As shown by Quinn et al [22], the SRS in serial dilution
should exhibit a sigmoidal shape when plotted on an OD-log10
dilution scale. The 4-PL function fits these data with a high degree
of accuracy and extends the range of the assay, thus providing a
more precise measurement of antibody concentration for patient
sera [20–22]. Furthermore, 8 wells per ELISA plate were assigned
as internal controls, consisting of two blanks (no sample with/
without secondary antibody), a positive serum and urine control,
and negative serum and urine control. The ELISA was qualified
for accuracy and precision as previously described [22].
Reliable Detection Limit (RDL) of the indirect ELISA
Figure S1 shows a graphic representation of the methods used
to derive the RDL, which was used as the threshold above which
a serum or urine sample was considered positive for antibodies
against OV antigen. Figure S1 Panels A, C, E and G show the
mean of the combined SCCs for each antibody-antigen pair (e.g.,
serum IgG1 to OV antigen) and their 95% CI intervals. Figure
S1 Panels B, D, F and H show the derivation of the RDL. In a
manner similar to Quinn et al. [22], the RDL was derived from
the level of AUs for each anti-OV-antigen antibody correspond-
ing to the interpolated intersection of the upper 95% CI
asymptote with the lower-95% CI of the standards data as
shown Figure S1 Panels B, D, F, and H. A human serum or urine
supernatant sample with Arbitrary Antibody units above the
RDL was defined as ‘‘reactive’’ (positive) and those with Arbitrary
Antibody units below the RDL as ‘‘nonreactive’’ (negative) as
shown in Table 2.
Indirect ELISA performance characteristics
Again following Quinn et al., [22], we defined ELISA assay
‘‘accuracy’’ as the exactness of the assay to measure a known, true
value of urine anti-OV IgG and to measure it repeatedly and
expressed assay accuracy as the percent error between the assay-
determined values and the assigned value for that serum. A
percent error of #20% was considered the acceptable level of
accuracy for the ELISAs presented herein [22,25]. We also
defined assay ‘‘precision’’ according to Quinn et al [22,25] as the
measure of the degree of repeatability of an assay under normal
operating conditions, and expressed assay precision as the
coefficient of variation (CV) of the concentrations calculated for
the SCC dilutions within a single assay plate (intra-assay precision)
and between different assay plates (inter-assay precision) deter-
mined over time and controlling for different operators. Accept-
able levels of intra-assay and inter-assay precision are 10% and
20%, respectively [22,25]. The ‘‘goodness of fit’’ of each SCC was
used to determine how closely each SRS fit the 4-PL model.
Goodness of fit was expressed as the regression coefficient (R2) of
the SCC. An R2 value that approached unity (1.00) was indicative
of a good fit for the data to the curve [22,25] and these are shown
for each SCC in Figure S1 Panels A, C, E and G.
Table 2. Serum and urine antibodies to an Opisthorchis viverrini crude antigen extract by clinical group.
Serum Urine
IgG IgG1 IgG4 IgG
RDL` (AU) = 3.9 2.6 5.0 2.7
Pos Neg Pos Neg Pos Neg Pos Neg
N N (%) N (%) N (%) N (%) N (%) N (%) N N (%) N (%)
EN{ 40 40 (100) 0 (0) 37 (95) 2 (5) 6 (35) 11 (65) 15 5 (33) 10 (67)
OV+APF2 139 139 (100) 0 (0) 139 (100) 0 (0) 52 (51) 50 (49) 79 30 (38) 49 (62)
APF+ 117 117 (100) 0 (0) 117 (100) 0 (0) 59 (51) 57 (49) 103 64 (62) 39 (38)
CCA+ 98 98 (100) 0 (0) 94 (96) 4 (4) 11 (37) 19 (63) 8 8 (100) 0 (0)
`RDL or Reliable Detection Limit as shown in Supporting Figure 1 Panels B, D, F and H.
{The term EN refers to OV2 and APF2 individuals resident in OV endemic areas along the Chi River Basin in Khon Kaen, Thailand.
Positivity is determined by serum or urine samples having antibodies over the Reliable Limit of Detection (see Figure 1 Panels B, D, F, and H). Advanced periductal
fibrosis (APF) was determined by the ‘‘Gold Standard of abdominal ultrasound, and OV positivity by the ‘‘Gold Standard’’ of microscopic fecal exam. The CCA cases were
from (CCA) from the biological specimen repository of the Liver fluke and Cholangiocarcinoma Research Center, Khon Kaen University, Thailand.
doi:10.1371/journal.pntd.0002228.t002
Renal Biomarkers for Chronic Opisthorchiasis
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Clinical data analysis
Data distributions were assessed for normality. For normally-
distributed data, differences between AUs of antibody to OV
antigen were compared between different matrices (urine or sera) by
clinical groups or by different matrices using the intensity of OV
infection by Student’s t-test. Non-parametric data were compared
using the Mann-Whitney U-test. One-way ANOVA (normally
distributed data) or a Kruskal-Wallis tests (non-normally distributed
data) were used to determine statistically significant associations
among the aforementioned groups followed by a Bonferonni
corrected pairwise comparison when comparing pairs in each
group. All statistical analyses were performed using SAS 9.2. Results
were considered significant when the p-value was less than ,0.05.
Sensitivity was calculated as the number of individuals with
serum or urine IgG to OV antigen above the cut-off set for each
assay as determine by Receiver Operator Characteristic (ROC)
curves obtained with ROCKIT1.1 software. Specificity was
calculated as the number of individuals with serum or urine IgG
to OV antigen below the ‘‘cut-off’’ set for each assay divided by
the total number of control individuals (EN or APF2). As we
propose these assays as screening tests, we selected the cut-offs to
achieve the highest sensitivity without losing specificity: i.e., the
best trade off between high sensitivity and modest specificity. The
area under the curve (AUC) is a measure of the ROC’s validity.
The 45-degree line in each ROC curve analysis subsumed an area
equal to 0.50 and is equivalent to using a coin toss procedure to
classify participants. To calculate the positive predictive values
(PPV) for each assay, we used a 50% prevalence of infection OV as
determined by microscopic fecal exam in the age range of 20 to 60
years from our previous studies of the KKCC [7,8,18]. The
following formula was used to estimate the Positive Predictive
Value with prevalence set at 0.50 for each:
PPV~
Sensitivity{Prevalence
Sensitivity|Prevalenceð Þ{ 1{Specificityð Þ 1{Prevalenceð Þ
Results
Characteristics of the study sample
Table 1 shows the age of the study participants by clinical
group. Of the two hundred and ninety-six (296) individuals who
provided fecal specimens for examination by FECT (Groups 1, 2
and 3), 256 (86.4%) were confirmed to be infected with OV by
microscopic fecal exam. One hundred and seventeen individuals
(n = 117) were assigned the status of APF+ and assigned the status
of case. Additionally, 139 OV+ and APF2 individuals were
assigned the status of age, sex and ‘‘nearest-eligible-neighbor’’
matched controls (Group 2). Note that the larger sample size of the
controls is due to the fact that 22 of the cases were matched with
two controls for greater sample size. Forty (n = 40) OV2 and
APF2 individuals were assigned the status of Endemic Normals.
Finally, 98 serum samples were obtained by simple random
sampling from the biological specimen bank of the Liver Fluke and
Cholangiocarcinoma Research Center, Khon Kaen University,
Thailand; only 8 of these individuals has urine samples. Fecal
specimens were not available for the CCA patients.
Performance characteristics of the anti-OV IgG ELISA
Figure S2 shows the parallelism of each SCC by plotting
linearized versions of each SCC for serum IgG (P = 0.225) (Figure
S2 Panel A), serum IgG1 (P = 00.240) (Figure S2 Panel B), serum
IgG4 (P = 0.136) (Figure S2 Panel C), and urine IgG (P = 0.402)
(Figure S2 Panel D). The regression slopes of the fitted SCCs were
not significantly different as determined by ANOVA (p.0.05),
indicating parallelism among each group of SCCs [24].
Serum IgG and IgG1 against OV antigen were detected in
nearly all individuals (100% and 98%, respectively)
including individuals in the Endemic Normal (EN) group
Using the RDL shown in Figure S1 Panel B as the detection
threshold, Table 2 shows that serum IgG against OV antigen was
detected in all individuals (100%; n = 394) in the study. Similarly,
Table 2 also shows that using the RDL shown in Figure S1 Panel D
as the detection threshold for anti-IgG1 OV antigen, nearly all (98%;
n = 387) of individuals in the study had detectable levels of this serum
antibody to OV antigen, again, regardless of OV or clinical status.
Finally, using the RDL shown in Figure S1 Panel F as the detection
threshold, Table 2 shows that a third to half of the individuals in each
clinical group had detectable levels of IgG4 to OV antigen.
Only half of APF+ individuals had detectable levels of
urine IgG to OV antigen
Using the RDL as the detection threshold (Figure S1 Panel H),
Table 2 shows that over 60% of APF+ individuals had detectable
levels of IgG to OV antigen in their urine. A lower proportion
(38%) of individuals who were OV+ and APF2 (matched controls)
had detectable levels of urine IgG to OV antigen. All eight (n = 8)
of the CCA patients who had urine samples had detectable levels
of IgG to OV in their urine.
Levels of serum IgG and IgG1 were significantly elevated in
individuals with medium to heavy OV infection ($500
eggs per gram of feces, epg) compared to EN group and to
individuals with lighter levels of OV infection (1–499 epg)
Levels of serum IgG (Figure 1 Panel A) and serum IgG1 (Figure 1
Panel B) to OV antigen were significantly higher (P,0.001, for both)
in individuals with both lighter (1–499 epg) or heavier ($500 epg) OV
infections compared to EN individuals (no eggs in feces). In addition,
individuals with heavier OV infection had higher levels of serum
IgG1 to OV antigen than individuals with lighter OV infection
(Figure 1 Panel B). Levels of urine IgG were not significantly elevated
in any of the infection groups (Figure 1 Panel D).
Urine IgG to OV antigen was significantly elevated in
individuals with advanced periductal fibrosis (APF+) or
with histologically proven CCA compared to EN and
APF2 controls
Figure 2 Panel D shows that urine levels of IgG to OV antigen
were significantly higher (P,0.001) in APF+ individuals than
individuals in the EN or APF2 groups: i.e., on average, 21 times
higher in APF+ individuals than EN individuals and 7 times higher in
APF+ individuals than APF2 individuals. Similarly, Figure 2 Panel D
shows that urine levels of IgG to OV antigen were significantly higher
(P,0.001) in CCA+ individuals than individuals in the EN, APF2,
and APF+ groups. On average, urine levels of IgG to OV antigen
were 158 times higher in CCA+ individuals than EN individuals; 21
times higher in CCA+ individuals than APF2 individuals; and 7
times higher in CCA+ individuals than APF+ individuals.
No association was observed between serum levels of
IgG to OV antigen and urine levels of IgG to OV-antigen
Figure S3 Panel A shows that there is no association between levels
of serum IgG to OV antigen and urine levels of IgG to OV antigen in
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the same individuals. This was found for all infection and clinical
categories. Figure S3 Panel B shows that few of OV+ individuals in
either group (APF2 or APF+) had proteinuria as determined by
point-of-care testing using a strip-based urine reagent device, with a
positive urine dipstick test for protein defined by a color change of
‘‘+’’ or greater that equates to at least 30 mg/L of protein.
Elevated levels IgG1 to OV-antigen had the best area
under the curve (AUC) as well as the highest positive
predictive value (PPV) for OV infection
Table 3 shows the area under the curve (AUC) for ROC curve
analyses with PPVs determined using 50% prevalence: e.g., serum
IgG against OV antigen had an AUC of 0.68 and a PPV of 0.60
using the cutoff of 35.66 AUs resulting from ROC curve analysis
of the highest possible sensitivity without a decrease in the
specificity of the assay. Using these cutoffs, we estimated crude and
adjusted Odds Ratios (95%CIs) for the risk of OV-positivity. The
ROC curves for serum IgG1 against OV-antigen had the best
AUC with 0.68 using an antibody cutoff of 9.21 AUs. Using this
cutoff resulted in a PPV of 0.61, as well as an adjusted OR of 2.51
(95%CI 1.26, 5.00) for the risk of OV positivity. Despite a poor
AUC and a weak PPV, urine IgG indicated significant risk for OV
infection with a crude OR of 7.60 (95%CI 3.56, 16.20) and an
adjusted OR of 7.68 (95%CI 3.58, 16.50).
Elevated levels IgG1 to OV antigen also had the best AUC
as well as the highest PPV for heavy OV infection
Table 4 shows that elevated levels of serum IgG1 to OV antigen
had the best combination of sensitivity and specificity for the
prediction of heavy OV infection (.500 epg) compared to
individuals negative for OV. In addition, elevated levels of serum
IgG and IgG1 to OV antigen showed excellent capacity to indicate
risk of high OV infection as determined by significant crude and
adjusted ORs (Table 4). Though serum IgG4 to OV antigen and
urine IgG to OV antigen showed moderate discriminatory
capacity for OV infection, Table 4 shows that elevated levels of
urine IgG to OV antigen could still predict risk of OV infection as
shown in an adjusted OR of 7.88 (95%CI: 2.64, 23.51).
Elevated levels of urine IgG to OV-antigen can detect
individuals who are APF+ compared to EN or APF2
individuals
Table 5 shows that elevated levels of urine IgG could
discriminate between individuals who were APF positive from
EN individuals, with an AUC of 0.72 and a PPV of 0.67 using a
cutoff of 4.00 AUs of urine IgG to OV antigen. In addition, urine
IgG to OV antigen showed significant crude and adjusted ORs for
predicting risk of APF: crude OR = 6.34 (95%CI: 2.75, 14.66) and
Figure 1. The relationship between Opisthorchis viverrini infection and serum and urine antibodies to OV antigen. The status of O.
viverrini infection was determined by microscopic fecal examination. Individuals were categorized as to the intensity of OV infection by the geometric
mean of the eggs per gram of feces as follows: ‘‘negative’’ or ‘‘0’’ (no eggs detected in feces), ‘‘lightly infected (1–499 eggs per gram of feces), or
‘‘medium-to heavily‘‘ infected ($500 eggs per gram of feces). In the case of CCA patients, the serum and urine specimens were obtained from
histologically proven cases of opisthorchiasis-associated cholangiocarcinoma from the biological specimen repository of the Liver fluke and
Cholangiocarcinoma Research Center, Khon Kaen University, Thailand. The levels of the following antibodies were determined to a crude adult OV
antigen extract by indirect ELISA: serum IgG (Panel A), serum IgG1 (Panel B), serum IgG4 (Panel C) and urine IgG (Panel D). The Ab levels of each
infection group was estimated by the mean shown as the red horizontal line in each group and tested using ANOVA followed by Pairwise Testing of
each group with a Bonferroni correction for multiple testing.
doi:10.1371/journal.pntd.0002228.g001
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adjusted OR = 6.69 (95%CI: 2.87, 15.58). Elevated levels of urine
IgG to OV antigen could also differentiate individuals with APF
from matched APF2 controls as well as an OR which indicated
risk of APF in adjusted and unadjusted models. Table S2 shows
that serum IgG to OV antigen could also modestly discriminate
APF positive individuals from individuals from the EN group, with
an AUC of 0.52 and a PPV of 0.52 and an adjusted OR of 2.71
(95%CI: 1.26, 5.84).
Figure 2. The relationship between hepatobiliary pathologies and levels of serum and urine antibodies to OV antigen. Individuals
who were positive for O. viverrini but negative for APF by abdominal US were defined as ‘‘controls’’ and matched with cases by age (by ten year
bands), sex, and nearest eligible neighbor method. The levels of the following antibodies (Ab) were determined to a crude adult OV antigen extract
by indirect ELISA: serum IgG (Panel A), serum IgG1 (Panel B), serum IgG4 (Panel C) and urine IgG (Panel D). The Ab level of each infection group
was estimated by the mean shown as the red horizontal line in each group and tested using analysis of variance (ANOVA) followed by pairwise
testing of each group with Bonferroni correction for multiple testing.
doi:10.1371/journal.pntd.0002228.g002
Table 3. Clinical epidemiology of serum and urine IgG to OV antigen for the detection of OV infection.
Odds Ratio (95%CI Lower, Upper)
Assay AUC{ Cut Off (AUs*) Sensitivity (95%CI) Specificity (95%CI) PPV** Crude Adjusteda
Serum IgG 0.68 .35.66 0.80 (0.75, 0.85) 0.46 (0.31, 0.61) 0.60 2.50 (1.26, 4.96) 2.50 (1.25, 4.98)
Serum IgG1 0.68 .9.21 0.80 (0.75, 0.85) 0.49 (0.34, 0.64) 0.61 2.57 (1.29, 5.10) 2.51 (1.26, 5.00)
Serum IgG4 0.51 .8.37 0.61 (0.52, 0.69) 0.33 (0.10, 0.65) 0.48 1.16 (0.58, 2.31) 1.03 (0.51, 2.06)
Urine IgG 0.56 .3.74 0.70 (0.61, 0.79) 0.33 (0.10, 0.651) 0.51 7.60 (3.56, 16.20) 7.68 (3.58, 16.50)
{Area Under the Curve;
*Arbitrary Units of antibody;
**Positive predictive value;
aAdjusted for age and sex.
The detection of OV infection was determined by microscopic fecal exam. The positive predictive value (PPV) was estimated using (50%) prevalence from field studies in
[7,8,18]. Odds Ratios and their 95% Confidence Intervals were based on the ‘‘cut-offs’’ obtained from Receiver Operator Characteristic (ROC) curve analyses Odds Ratios
were adjusted for age and sex. Odds Ratios calculated against individuals with no detectable levels of antibody in urine.
doi:10.1371/journal.pntd.0002228.t003
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Levels of urine IgG to OV-antigen can discriminate
between individuals with confirmed CCA against other
OV-related pathologies
Table 5 also shows that elevated levels of urine IgG to OV
antigen can discriminate better than serum antibodies individuals
with confirmed CCA versus endemic normals, with an AUC of
0.97 for the ROC curve analysis and a PPV of 0.79 when the
antibody cutoff of 2.84 AU is used. In addition, Table 5 shows that
elevated levels of urine IgG to OV antigen are strongly associated
with CCA: crude OR = 85.00 (95%CI: 19.89, 362.0) and adjusted
for sex and age OR = 71.13 (95%CI: 15.13, 334.0). Table S3
shows that serum antibodies to OV antigen do not have the
sensitivity nor specificity to be predictive of CCA nor the crude
and adjusted Odds Ratios to indicate risk for CCA compared to
urine IgG to OV antigen.
Discussion
In the current manuscript, we show that more than half of the
individuals resident in endemic areas along the Chi River Basin in
Khon Kaen, northeastern (Isaan) Thailand have detectable levels
of urine IgG to adult OV antigen extract. Moreover, elevated
levels of urine IgG to OV antigen were not associated with either
the intensity of OV infection (as measured by fecal egg counts) or
the levels of serum antibodies to OV antigen. These findings
support our hypothesis that urine IgG to OV antigen most likely
represents renal pathology in the form of immune complex-
mediated structural damage to the glomeruli (injury of podocytes)
and to the tubular interstitium as observed in animal models of
OV infection [10,11]. Interestingly, we found that IgG to OV
antigen was detectable in the urine at concentrations 21-times
higher in individuals with OV-induced APF and 158-times higher
in individuals with OV induced CCA compared to controls. As
shown in Table 5, individuals with elevated urine IgG to OV
antigen had an increased risk for APF (adjusted OR of 6.69;
95%CI: 2.87, 15.58) and an increased risk for CCA (adjusted OR
of 71.13; 95%CI: 15.13, 334.0) than individuals who had no
detectable levels of urine IgG to OV antigen. We also found that a
single measurement of urine IgG to OV antigen had good
predictive value for the detection of both APF and CCA compared
to age, sex, and nearest-neighbor matched non-cases (either EN or
APF negative controls). Hence, as shown in Figure 3, our study
adds to the literature on the pathophysiology of opisthorchiasis the
possibility that renal pathology occurs simultaneously with the
advanced hepatobiliary pathologies more commonly associated
with this infection and that renal pathology can be detected by
elevated levels of urine IgG to OV antigen [10,11]. A urine-based
assay that could simultaneously evaluate the clinical status of
Table 4. Clinical epidemiology of serum and urine IgG to OV antigen to detect levels of OV infection.
Odds Ratio (95%CI Lower, Upper)
Assay AUC{ Cut Off (AUs*) Sensitivity (95%CI) Specificity 95%CI) PPV** Crude Adjusteda
Serum IgG 0.82 .46.41 0.91 (0.77, 0.98) 0.59 (0.43, 0.73) 0.69 7.90 (2.80, 22.33) 9.62 (3.21, 28.79)
Serum IgG1 0.83 .12.04 0.91 (0.77, 0.98) 0.62 (0.47, 0.76) 0.71 9.20 (3.19, 26.52) 12.72 (4.11, 39.41)
Serum IgG4 0.68 .11.24 0.79 (0.59, 0.92) 0.42 (0.15, 0.72) 0.57 4.82 (1.79, 12.95) 4.23 (1.54, 11.85)
Urine IgG 0.58 .5.78 0.68 (0.43, 0.87) 0.58 (0.28, 0.85) 0.62 6.09 (2.19, 16.90) 7.88 (2.64, 23.51)
{Area Under the Curve;
*Arbitrary Units of antibody;
**Positive predictive value;
aAdjusted for age and sex.
The sensitivity and specificity of serum IgG, IgG1, and IgG4 and urine IgG to OV antigen extract for ‘‘medium-heavy’’ intensity of infection defined as $500 OV eggs per
gram of feces by microscopic fecal exam. The positive predictive value (PPV) was estimated using (50%) prevalence from field studies in [7,8,18]. Odds Ratios and 95%
Confidence Intervals were based on the ‘‘cut-off’’ points as obtained by Receiver Operator Characteristic (ROC) curve analysis. Odds Ratios were adjusted for age and
sex. Odds Ratios calculated against individuals with no detectable levels of antibody in urine.
doi:10.1371/journal.pntd.0002228.t004
Table 5. Clinical epidemiology of serum and urine IgG to OV antigen to detect APF and CCA.
Odds Ratio (95%CI Lower, Upper)
Groups AUC{ Cut Off (AU*) Sensitivity (95%CI) Specificity (95%CI) PPV** Crude Adjusteda
APF+ vs. EN` 0.72 .4.00 0.67 (0.58, 0.75) 0.66 (0.22, 0.96) 0.67 6.34 (2.75, 14.66) 6.69 (2.87, 15.58)
APF+ vs. APF20.65 .0.89 0.71 (0.61, 0.79) 0.52 (0.40, 0.63) 0.60 1.20 (1.23, 3.26) 1.98 (1.21, 3.23)
CCA vs. EN 0.97 .2.84 1.00 (0.63, 1.00) 0.73 (0.45, 0.92) 0.79 85.00 (19.89, 362.0) 71.13 (15.13, 334.0)
{Area Under the Curve;
*Arbitrary Units of antibody;
**Positive predictive value;
`EN refers to Endemic Normals (Group 1);
aAdjusted for age and sex.
APF refers to advanced perdicutal fibrosis as determined by abdominal ultrasound. CCA refers to confirmed cholangiocarcinoma. The positive predictive value (PPV)
used a prevalence of 50% from field studies in [7,8,18]. Estimations of risk by Odds Ratios and 95% Confidence Intervals based on the ‘‘cut-offs’’ obtained by Receiver
Operator Characteristic (ROC) curve analyses. Odds Ratios were adjusted for age and sex. Odds Ratios calculated against individuals with no detectable levels of
antibody in urine.
doi:10.1371/journal.pntd.0002228.t005
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individuals for both renal and hepatobiliary pathologies from
chronic opisthorchiasis would be of profound benefit in Southeast
Asia, especially in the resource-limited settings of the Mekong
Basin region countries of Thailand, Laos and Cambodia.
Antibodies have long been known to play a central role in the
immune response to Opisthorchis viverrini infection [14,26–36].
Individuals and animals infected with this food-borne trematode
show high serum/plasma levels of the classic antibodies associated
with helminth infections such as IgG, IgG1, IgG4 and IgE to
crude OV antigen extracts. As such, it has been hypothesized that
circulating antibodies to OV antigens may ‘‘leak’’ from the plasma
into the urine at levels proportionate to the intensity of OV
infection [14,16]. However, as seen in these other studies [14,16],
we found that urine IgG to OV antigen is a poor method for
diagnosing OV infection and an even poorer method for
predicting the intensity of OV infection (Tables 3 and 4). In
addition, we observed only weak correlations between circulating
levels of serum IgG to OV antigen and levels of urine IgG to OV
antigen. These findings are consistent with our current under-
standing of the pathophysiology of urine proteinuria (e.g. IgG in
urine) from various clinical settings [9,11,17,37,38]. A healthy
glomerular capillary wall should efficiently restrict the passage of
IgG from the blood (plasma) into Bowman’s space on the basis of
this intact immunoglobulin’s molecular size, electrical charge, and
steric configuration; for example, the restrictive pore radius of the
renal glomerular filter is 45 Ångstroms (Å), whereas intact IgG has
a molecular radius of 55 Å (see [17] for excellent review).
Additionally, IgG is a cationic protein, which means it binds
strongly to the negatively charged proximal tubule cells [17].
Hence, even if small amounts of IgG are filtered into Bowman’s
space and, thereby into the tubular lumen, they would be readily
reabsorbed in the proximal tubule. In keeping with similar findings
in experimental animal models of OV infection [10], we
hypothesize that the frequent observation of IgG in the urine of
OV infected individuals reflects glomerulopathy. More specifically,
we suspect that it reflects structural damage to the glomerular
capillary wall characterized by injured podocytes, resulting in
increased glomerular permeability or increased glomerular pore
size that allows for passage of macromolecules such as IgG. In
addition, the reabsorption capacity of the epithelial cells of the
proximal tubules may also be impaired. Both glomerular and
tubular damage are cardinal signs of kidney disease [17,37,38].
The fact that the IgG detected in the urine is specific for OV
antigen leads us to postulate that the observed renal pathology is
the result of immune complex deposition similar to that observed
in animal models of OV [10]. Renal pathology caused by immune
complex deposition has been described in association with other
parasitic helminth infections such as schistosomiasis [9]. Immune
complexes are putatively deposited in the glomerular subendothe-
lium, resulting in activation of complement, chemoattraction of
leukocytes, and an inflammatory reaction that leads to disruption
of the glomerular basement membrane with enlargement of
Figure 3. Renal pathology in the progression from Opisthorchis viverrini infection to cholangiocarcinoma. Figure 3 is an adaption of the
pathway to pathogenesis of OV infection as previously published in [40]. Here, we have added in the green box the role of renal pathology the form
of a microproteinuria in the progression from chronic opisthorchiasis to CCA. This renal pathology most likely results from sustained systemic effects
of the parasitic infection on the host immune response (i.e., immune complex–mediated glomerulopathy). Despite the lack of a common pathogenic
mechanism, the renal and hepatobiliary pathologies associated with OV infection develop simultaneously in the laboratory animal model and (as
hypothesized in this manuscript) in humans chronically infected with OV as well. As such, a biomarker for renal pathology could be equally indicative
of risk for APF and CCA, i.e., ‘‘syndromic biomarker’’ for the advanced pathologies associated with chronic opisthorchiasis.
doi:10.1371/journal.pntd.0002228.g003
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glomerular barrier pores, thus permitting passage of high
molecular weight (HMW) macromolecules such as IgG to which
the basement membrane is normally impermeable [17,38]. The
increased load of HMW macromolecules in the tubular lumen
leads to saturation of the re-absorptive mechanism by tubular cells.
As mentioned above, the renal pathology observed in OV-infected
hamsters is a mesangial proliferative glomerulonephritis with the
immune complexes consisting of IgG, complement component 3
(C3), and OV antigen [10,11,39]. Immune complexes accumulate
in the glomeruli of the hamster kidney either by (a) passive
trapping of circulating immune complexes or (b) in situ formation
by the binding of antibody to OV-antigen that was previously
deposited in the glomeruli. During the course of a single
experimental OV infection, hamsters develop progressive sclerosis
of glomeruli, tubular atrophy, as well as interstitial inflammation
and fibrosis that appear to be coincident with the development of
bile duct fibrosis and bile duct cancer [10].
However, not all individuals, who are chronically infected with
O. viverrini, develop renal or hepatobiliary abnormalities. From our
community-based studies in OV endemic areas in northeastern
Thailand, we have observed that a subset of individuals infected
with OV respond to the chronic inflammation from OV infection
response with pathologies [7,8,18]. We have termed these
individuals as having a ‘pro-inflammatory’ phenotype [40]. The
current study adds to our hypothesis evidence that the ‘pro-
inflammatory’ phenotype extends to renal pathology associated
with chronic opisthorchiasis (i.e., APF and CCA). We suspect that
individuals with the ‘pro-inflammatory phenotype’ have a
dysregulation of inflammatory cytokine production in response
to chronic fluke infection, which manifests as inflammation in the
renal filters (glomeruli), enlarging them to allow passage of
macroproteins (e.g., intact IgG to OV antigen) from the plasma.
As seen in the hamster model, we also suspect that over time there
is a progressive obsolescence of the glomeruli, tubular atrophy,
interstitial inflammation, and renal fibrosis associated with this
proteinuria [10,11,39]. As urine IgG to OV antigen is an easily
accessible biomarker, we suggest that it could serve as a biomarker
for the multiple inflammation-related pathologies from opisthor-
chiasis.
An important question arising from our study is the absence of
detectable proteinuria by means of point-of-care testing using a
strip-based urine reagent device. Theoretically, the increased
permeability of the glomerular barrier that allows the filtering of
IgG should also result in proportional losses of albumin into the
urine, which is the principal protein component detected by the
urine dipstick test [37]. There are two possibilities that explain the
false negative urine dipstick results. First, total protein concentra-
tion in urine depends on degree of hydration (i.e., the specific
gravity of the urine). False negative results may relate to the
manner in which the urine samples were collected [37], including
collection of the entire urine sample and not a mid-stream urine
sample (which represents urine from the kidneys) or the collection
of first morning urine (24 hour urine sample), which represents an
accumulation of urine that could result in a dilution of the sample
that would decrease the sensitivity of the dipstick test to detect
proteinuria [37]. On the other hand, the indirect ELISA would be
much more sensitive to the presence of IgG in urine than a dipstick
test because (a) the urine is concentrated in a preparation step
prior to immunoassaying and (b) the monoclonal antibodies to
human IgG used in the ELISA are much more sensitive and
specific than the dipstick’s colorimetric method which is used to
primarily detect albumin in the urine. The second hypothesis is the
possibility of a restrictive mechanism that prohibits the filtering of
albumin into urine but that allows leakage of IgG. Numerous
investigators (see [37] for review) have observed that the
movement of albumin into Bowman’s space is not restricted by
pore size, but by its negative charge and the consequent repulsive
electrostatic interactions with the negatively charged glomerular
endothelium. Hence, it is quite possible that the presence of IgG in
the urine due to OV infection is not accompanied by appreciable
albuminuria—a hypothesis that clearly deserves further study.
A final issue is the relationship between the concurrent renal
and hepatobiliary pathologies observed in this study. The strongest
associations in the current study were between elevated urine IgG
to OV antigen and APF or CCA: individuals with elevated levels
of urine IgG to OV antigen had a 6 times greater risk of having
APF and a 71-times greater risk of having CCA (Table 5 adjusted
OR) than individuals with no detectable IgG to OV antigen in
their urine. Additionally, a single measurement of urine IgG to
OV antigen had a good positive predictive value for the detection
of both APF and CCA. However, as shown in the hamster model
for OV-induced bile duct fibrosis and CCA [10], no plausible
physiologic relationship exists between the hepatobiliary and renal
pathologies induced by chronic OV infection. It appears that they
are the result of two distinct pathological mechanisms that develop
simultaneously during OV infection. As we have written
extensively, hepatobiliary pathology from chronic opisthorchiasis
is likely the result of repeated injury sustained by the biliary
epithelium from a combination of the mechanical, toxic, and
immune insults associated with the presence of the fluke in the bile
duct [for review see [8,18]). As individuals are infected with O.
viverrini for many years (often a lifetime), a persistent cycle of tissue
damage and repair takes place in the intrahepatic biliary ducts,
creating a chronic inflammatory milieu that stimulates periductal
fibrogenesis and tumorigenesis [8,18]. The renal injury observed
herein is the likely the consequence of chronic OV infection,
resulting from the sustained systemic effects of the parasitic
infection on the host immune response (i.e., immune complex–
mediated glomerulopathy).
Despite the lack of a common pathogenic mechanism, the renal
and hepatobiliary pathologies associated with OV infection
develop simultaneously in the animal model and probably in
humans as well. As such, a biomarker for renal pathology could be
equally indicative of risk for APF and CCA. It should also be noted
that as early as 1990, Mairiang et al. [12], reported acute renal
failure in nearly all patients with obstructive jaundice due to CCA
caused by opisthorchiasis. This is in keeping with our own findings
of elevated urine IgG to OV antigen in CCA cases. However, in
the case of end-stage CCA, the finding of proteinuria may reflect
‘‘hepatorenal syndrome’’ (HRS), which is a common complication
of patients with advanced forms of liver disease such as CCA and
cirrhosis [13] and is caused by intense vasoconstriction of the renal
circulation, leading to a pronounced reduction in glomerular
perfusion and filtration [13]. HRS generally occurs in late stages of
severe liver disease, when patients have already manifested
significant complications of cirrhosis. HRS is an acute condition
with a very poor prognosis. As such, there remains some question
as to whether the renal pathology, presumably chronic in nature,
that is seen among individuals with opisthorchiasis-induced APF is
the same as that seen among CCA cases, as the latter may reflect
HRS rather than immune complex associated glomerulonephritis.
As shown by our community-based studies [7,8,18], chronic O.
viverrini infection results in a persistent immunological and
inflammatory challenge to the human host. For the first time,
we have shown that chronic OV infection may also result in a
significant burden of renal disease in the form of immune
complex-mediated glomerulopathy. The importance of this study
is the observation that this renal pathology can be readily detected
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in the urine by an immunoassay for IgG against OV-antigen and
that elevated levels of urinary IgG to OV-antigen are also strongly
associated with hepatobiliary pathologies. In future studies, we
plan to improve on the sensitivity and specificity of this biomarker
by screening urine for the specific antigens recognized by IgG in
the crude adult OV-antigen extract used here. Recent advances in
immunomics, in which the O. viverrini proteome can be assembled
on a microarray chip, allows for high-throughput screening of
urine samples to determine the most abundantly recognized
proteins. These could subsequently be developed as recombinant
proteins as reagents for urine diagnostic tests. As such, screening
for urinary IgG to specific recombinant OV antigens might be
used to indicate risk of several pathologies that can arise from
chronic opisthorchiasis, and thereby be used as a ‘‘syndromic
biomarker’’ of chronic opisthorchiasis.
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